CAT · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $67.59B | $64.81B | $67.06B | $59.43B | $50.97B | $41.75B | $53.80B | $54.72B |
| Cost of Revenue | $44.75B | $40.20B | $42.77B | $41.35B | $35.51B | $29.08B | $36.63B | $37.00B |
| Research & Development | $2.15B | $2.11B | $2.11B | $1.81B | $1.69B | $1.42B | $1.69B | $1.85B |
| Selling, General & Administrative | $6.99B | $6.67B | $6.37B | $5.65B | $5.37B | $4.64B | $5.16B | $5.48B |
| Operating Expenses | $56.44B | $51.74B | $54.09B | $51.52B | $44.09B | $37.20B | $45.51B | $46.43B |
| Operating Income | $11.15B | $13.07B | $12.97B | $7.90B | $6.88B | $4.55B | $8.29B | $8.29B |
| Other Income / (Expense) | $892.00M | $813.00M | $595.00M | $1.29B | $1.81B | -$44.00M | -$57.00M | -$67.00M |
| Income Before Taxes | $11.54B | $13.37B | $13.05B | $8.75B | $8.20B | $4.00B | $7.81B | $7.82B |
| Provision for Income Taxes | $2.77B | $2.63B | $2.78B | $2.07B | $1.74B | $1.01B | $1.75B | $1.70B |
| Net Income | $8.88B | $10.79B | $10.34B | $6.71B | $6.49B | $3.00B | $6.09B | $6.15B |
| Basic EPS | $18.90 | $22.17 | $20.24 | $12.72 | $11.93 | $5.51 | $10.85 | $10.39 |
| Diluted EPS | $18.81 | $22.05 | $20.12 | $12.64 | $11.83 | $5.46 | $10.74 | $10.26 |
| Basic Shares Outstanding | 470.00M | 486.70M | 510.60M | 526.90M | 544.00M | 544.10M | 561.60M | 591.40M |
| Diluted Shares Outstanding | 472.30M | 489.40M | 513.60M | 530.40M | 548.50M | 548.60M | 567.50M | 599.40M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $24.87 | $23.80 | $26.11 | 13 | ↑2 ↓1 |
| Dec 2027 | $31.13 | $27.88 | $35.09 | 13 | ↑2 ↓1 |
| Dec 2028 | $38.28 | $34.31 | $43.82 | 6 | ↑1 ↓0 |
| Dec 2029 | $47.69 | $47.69 | $47.69 | 1 | ↑0 ↓0 |
